Intrexon | Capitale Ordinario





Capitale Ordinario Cambiamento Data
Agenus USD 266K 30K 2025-03
Alaunos Therapeutics USD 2.21M 2.2M 2025-09
Amgen USD 539M 1000K 2025-12
Anika Therapeutics USD 143K 1000 2025-03
Arrowhead Research USD 135.7M 2.44M 2025-09
AstraZeneca USD 1.55B 1.16B 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Gilead Sciences USD 1.24B 0 2025-09
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Heron Therapeutics USD 1.52M 14K 2024-09
Incyte USD 196.13M 2.01M 2025-09
Intrexon USD 0 0 2024-06
Karyopharm Therapeutics USD 13K 0 2024-09
Ligand Pharmaceuticals USD 20K 0 2025-03
MacroGenics USD 63.26M 62.63M 2025-09
MannKind USD 307.03M 303.99M 2025-09
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.94B 23.4M 2025-06
Rigel Pharmaceuticals USD 17K 158K 2024-06
Roche Holding CHF 795.62M 699.54K 2025-12
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
Veracyte USD 78.67M 73K 2025-09
Xencor USD 71.34M 46K 2025-09


Intrexon Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.